BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 34575885)

  • 21. Altered brain arginine metabolism in a mouse model of tauopathy.
    Vemula P; Jing Y; Zhang H; Hunt JB; Sandusky-Beltran LA; Lee DC; Liu P
    Amino Acids; 2019 Mar; 51(3):513-528. PubMed ID: 30604097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TFEB Overexpression in the P301S Model of Tauopathy Mitigates Increased PHF1 Levels and Lipofuscin Puncta and Rescues Memory Deficits.
    Wang H; Wang R; Carrera I; Xu S; Lakshmana MK
    eNeuro; 2016; 3(2):. PubMed ID: 27257626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phospho-Tau Accumulation and Structural Alterations of the Golgi Apparatus of Cortical Pyramidal Neurons in the P301S Tauopathy Mouse Model.
    Antón-Fernández A; Merchán-Rubira J; Avila J; Hernández F; DeFelipe J; Muñoz A
    J Alzheimers Dis; 2017; 60(2):651-661. PubMed ID: 28922155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-acetylated-tau immunotherapy is neuroprotective in tauopathy and brain injury.
    Parra Bravo C; Krukowski K; Barker S; Wang C; Li Y; Fan L; Vázquez-Rosa E; Shin MK; Wong MY; McCullough LD; Kitagawa RS; Choi HA; Cacace A; Sinha SC; Pieper AA; Rosi S; Chen X; Gan L
    Mol Neurodegener; 2024 Jun; 19(1):51. PubMed ID: 38915105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dendritic Spine Remodeling and Synaptic Tau Levels in PS19 Tauopathy Mice.
    Walker CK; Greathouse KM; Boros BD; Poovey EH; Clearman KR; Ramdas R; Muhammad HM; Herskowitz JH
    Neuroscience; 2021 Feb; 455():195-211. PubMed ID: 33346120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biologic TNF-α inhibitors reduce microgliosis, neuronal loss, and tau phosphorylation in a transgenic mouse model of tauopathy.
    Ou W; Yang J; Simanauskaite J; Choi M; Castellanos DM; Chang R; Sun J; Jagadeesan N; Parfitt KD; Cribbs DH; Sumbria RK
    J Neuroinflammation; 2021 Dec; 18(1):312. PubMed ID: 34972522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains.
    Boluda S; Iba M; Zhang B; Raible KM; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2015 Feb; 129(2):221-37. PubMed ID: 25534024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathological tau and reactive astrogliosis are associated with distinct functional deficits in a mouse model of tauopathy.
    Patel H; Martinez P; Perkins A; Taylor X; Jury N; McKinzie D; Lasagna-Reeves CA
    Neurobiol Aging; 2022 Jan; 109():52-63. PubMed ID: 34655981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The GABAergic septohippocampal connection is impaired in a mouse model of tauopathy.
    Soler H; Dorca-Arévalo J; González M; Rubio SE; Ávila J; Soriano E; Pascual M
    Neurobiol Aging; 2017 Jan; 49():40-51. PubMed ID: 27743524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for accelerated tauopathy in the retina of transgenic P301S tau mice exposed to repetitive mild traumatic brain injury.
    Xu L; Ryu J; Nguyen JV; Arena J; Rha E; Vranis P; Hitt D; Marsh-Armstrong N; Koliatsos VE
    Exp Neurol; 2015 Nov; 273():168-76. PubMed ID: 26311071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model.
    van Olst L; Verhaege D; Franssen M; Kamermans A; Roucourt B; Carmans S; Ytebrouck E; van der Pol SMA; Wever D; Popovic M; Vandenbroucke RE; Sobrino T; Schouten M; de Vries HE
    Neurobiol Aging; 2020 May; 89():89-98. PubMed ID: 32008854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythropoietin-derived peptide treatment reduced neurological deficit and neuropathological changes in a mouse model of tauopathy.
    Choi YB; Dunn-Meynell AA; Marchese M; Blumberg BM; Gaindh D; Dowling PC; Lu W
    Alzheimers Res Ther; 2021 Jan; 13(1):32. PubMed ID: 33504364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired plasticity of cortical dendritic spines in P301S tau transgenic mice.
    Hoffmann NA; Dorostkar MM; Blumenstock S; Goedert M; Herms J
    Acta Neuropathol Commun; 2013 Dec; 1():82. PubMed ID: 24344647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alzheimer risk gene product Pyk2 suppresses tau phosphorylation and phenotypic effects of tauopathy.
    Brody AH; Nies SH; Guan F; Smith LM; Mukherjee B; Salazar SA; Lee S; Lam TKT; Strittmatter SM
    Mol Neurodegener; 2022 May; 17(1):32. PubMed ID: 35501917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deposition of Phosphorylated α-Synuclein and Activation of GSK-3β and PP2A in the PS19 Mouse Model of Tauopathy.
    Takaichi Y; Chambers JK; Ano Y; Takashima A; Nakayama H; Uchida K
    J Neuropathol Exp Neurol; 2021 Sep; 80(8):731-740. PubMed ID: 34151989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex difference in pathology and memory decline in rTg4510 mouse model of tauopathy.
    Yue M; Hanna A; Wilson J; Roder H; Janus C
    Neurobiol Aging; 2011 Apr; 32(4):590-603. PubMed ID: 19427061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progressive tauopathy in P301S tau transgenic mice is associated with a functional deficit of the olfactory system.
    Yang S; Kuan WL; Spillantini MG
    Eur J Neurosci; 2016 Sep; 44(6):2396-403. PubMed ID: 27422327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations in MAPT give rise to aneuploidy in animal models of tauopathy.
    Rossi G; Conconi D; Panzeri E; Paoletta L; Piccoli E; Ferretti MG; Mangieri M; Ruggerone M; Dalprà L; Tagliavini F
    Neurogenetics; 2014 Mar; 15(1):31-40. PubMed ID: 24218087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Onset of hippocampal network aberration and memory deficits in P301S tau mice are associated with an early gene signature.
    Przybyla M; van Eersel J; van Hummel A; van der Hoven J; Sabale M; Harasta A; Müller J; Gajwani M; Prikas E; Mueller T; Stevens CH; Power J; Housley GD; Karl T; Kassiou M; Ke YD; Ittner A; Ittner LM
    Brain; 2020 Jun; 143(6):1889-1904. PubMed ID: 32375177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy.
    Zhang B; Higuchi M; Yoshiyama Y; Ishihara T; Forman MS; Martinez D; Joyce S; Trojanowski JQ; Lee VM
    J Neurosci; 2004 May; 24(19):4657-67. PubMed ID: 15140937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.